↓ Skip to main content

Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

Overview of attention for article published in Frontiers in oncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
patent
3 patents

Citations

dimensions_citation
125 Dimensions

Readers on

mendeley
215 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Published in
Frontiers in oncology, September 2019
DOI 10.3389/fonc.2019.00849
Pubmed ID
Authors

Jesús García-Foncillas, Yu Sunakawa, Dan Aderka, Zev Wainberg, Philippe Ronga, Pauline Witzler, Sebastian Stintzing

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 215 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 32 15%
Student > Bachelor 28 13%
Student > Ph. D. Student 26 12%
Student > Master 16 7%
Other 10 5%
Other 25 12%
Unknown 78 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 47 22%
Medicine and Dentistry 30 14%
Immunology and Microbiology 13 6%
Agricultural and Biological Sciences 12 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 19 9%
Unknown 87 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2024.
All research outputs
#2,166,832
of 25,738,558 outputs
Outputs from Frontiers in oncology
#480
of 22,774 outputs
Outputs of similar age
#43,855
of 355,245 outputs
Outputs of similar age from Frontiers in oncology
#14
of 402 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,774 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 402 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.